IRCT20180418039349N1
Recruiting
Phase 3
Assessing the effectiveness, safety and patient satisfaction of intradermal tranxamic acid injection in comparision with fractional Q-Switch Nd-yag laser for melasma treatment
Skin and Stem Cell Research Center0 sites28 target enrollmentTBD
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Skin and Stem Cell Research Center
- Enrollment
- 28
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •women over the age of 18
- •moderate to severe melasma
Exclusion Criteria
- •patients who have received contraceptive drugs in the last 12 months
- •Patients with hemorrhagic or anticoagulant abnormalities
- •anticoagulant dug using
- •receiving another treatment for melasma at the same time
- •receive topical treatment for melasma for example hydroquinone one month before treatment.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical Evaluation of the Safety and Effectiveness of Harvest Autologous Platelet Concentrate and Harvest Autologous Thrombin for Treatment of Lower Extremity Chronic Diabetic UlcersISRCTN28965380Harvest Technologies Corp. (USA)59
Active, not recruiting
Not Applicable
Clinical Evaluation of the AqueSys Implant for the Treatment of ocular hypertension and open angle glaucomaOcular hypertension and open angle glaucomaEye - Diseases / disorders of the eyeACTRN12610000021077Aquesys Inc20
Recruiting
Phase 2
Clinical evaluation of the safety and effectiveness Oral capsules in the prevention and treatment of hair lossIRCT20190210042676N18Knowledge-based company of Janus20
Recruiting
Phase 2
Clinical evaluation of the safety and effectiveness of the nanofiber undereye pad to improve surface wrinkles and dark circles under the eyesIRCT20210130050179N9ano tarpak company10
Active, not recruiting
Phase 1
Evaluation of treatment effectiveness and safety of somatic cell based therapy for urinary incontinence in patients after radical prostatectomy.urinary incontinenceMedDRA version: 20.0Level: LLTClassification code: 10021643Term: Incontinence urinary Class: 10038359Therapeutic area: Diseases [C] - Male Urogenital Diseases [C12]CTIS2023-509812-27-00icolaus Copernicus University45